Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Laurie S ConklinPaula R Clemens

Abstract

We report a first-in-patient study of vamorolone, a first-in-class dissociative steroidal anti-inflammatory drug, in Duchenne muscular dystrophy. This 2-week, open-label Phase IIa multiple ascending dose study (0.25, 0.75, 2.0, and 6.0 mg/kg/day) enrolled 48 boys with Duchenne muscular dystrophy (4 to <7 years), with outcomes including clinical safety, pharmacokinetics and pharmacodynamic biomarkers. The study design included pharmacodynamic biomarkers in three contexts of use: 1. Secondary outcomes for pharmacodynamic safety (insulin resistance, adrenal suppression, bone turnover); 2. Exploratory outcomes for drug mechanism of action; 3. Exploratory outcomes for expanded pharmacodynamic safety. Vamorolone was safe and well-tolerated through the highest dose tested (6.0 mg/kg/day) and pharmacokinetics of vamorolone were similar to prednisolone. Using pharmacodynamic biomarkers, the study demonstrated improved safety of vamorolone versus glucocorticoids as shown by reduction of insulin resistance, beneficial changes in bone turnover (loss of increased bone resorption and decreased bone formation only at the highest dose level), and a reduction in adrenal suppression. Exploratory biomarkers of pharmacodynamic efficacy showed an a...Continue Reading

References

Feb 1, 1975·Archives of Neurology·K TakahashiB Matsuo
Jan 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·A J BeavilB J Sutton
Jan 1, 1996·European Journal of Clinical Pharmacology·G BabadjanovaH M Schulte
Apr 5, 2002·Annals of Clinical Biochemistry·C W Le RouxJ Alaghband-Zadeh
Aug 5, 2003·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·M L BianchiL Morandi
Jul 14, 2007·Neuromuscular Disorders : NMD·Ann-Charlott SöderpalmDiana Swolin-Eide
Mar 21, 2008·Journal of Child Neurology·Xiomara Q RosalesJerry R Mendell
Mar 13, 2009·PloS One·Jérôme RambertM Djavad Mossalayi
Apr 22, 2011·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Anna RufoAnna Teti
Jun 30, 2012·The Journal of Pharmacology and Experimental Therapeutics·Andreas R BaudyEric P Hoffman
Mar 19, 2013·Bioorganic & Medicinal Chemistry·Erica K M ReevesJohn M McCall
Sep 10, 2013·EMBO Molecular Medicine·Christopher R HeierKanneboyina Nagaraju
Nov 14, 2014·Cellular and Molecular Neurobiology·Blythe C DillinghamJesse M Damsker
Aug 8, 2015·Science Translational Medicine·Amy S RosenbergJanet Woodcock
Sep 1, 2015·Cell Reports·Alyson A FiorilloEric P Hoffman
Nov 29, 2015·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·B M MisofL M Ward
Jun 5, 2016·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Jesse M DamskerAnthony D Sandler
Aug 18, 2016·Scientific Reports·Yetrib HathoutEric P Hoffman
Oct 25, 2016·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J MaL M Ward
Apr 8, 2017·Liver International : Official Journal of the International Association for the Study of the Liver·Rachel J Church, Paul B Watkins
Oct 19, 2017·Autoimmunity Reviews·Arezoo Gowhari ShabgahAmirhossein Sahebkar
Apr 8, 2018·Nature Communications·William H HudsonEric A Ortlund

❮ Previous
Next ❯

Citations

Oct 20, 2018·Acta Physiologica·Werner J Z'Graggen, Joerg C Schefold
Feb 12, 2019·Journal of Clinical Pharmacology·Panteleimon D MavroudisWilliam J Jusko
Aug 28, 2019·Neurology·Eric P HoffmanUNKNOWN Cooperative International Neuromuscular Research Group
Mar 7, 2020·Expert Opinion on Pharmacotherapy·Sharon M GragesDaniel J Berlau
Aug 26, 2019·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Jesse M DamskerKanneboyina Nagaraju
May 21, 2020·Journal of Clinical Pharmacology·Xiaonan LiWilliam J Jusko
May 12, 2020·Journal of Neuromuscular Diseases·Kristin StrandbergCristina Al-Khalili Szigyarto
May 31, 2019·Nature Reviews. Neurology·Ingrid E C Verhaart, Annemieke Aartsma-Rus
Feb 13, 2019·Life Science Alliance·Christopher R HeierChristopher F Spurney
Apr 16, 2020·Toxicological Sciences : an Official Journal of the Society of Toxicology·Alastair KhodabukusNenad Bursac
Jul 22, 2020·Pharmacological Reports : PR·Agnieszka Łoboda, Józef Dulak
Sep 13, 2020·Proceedings of the National Academy of Sciences of the United States of America·Xu LiuEric A Ortlund
Sep 11, 2019·Journal of Clinical Pharmacology·Laurie S ConklinJohn van den Anker
Jan 5, 2021·Frontiers in Endocrinology·Leanne M Ward
Oct 27, 2020·Journal of Neuromuscular Diseases·Mattia QuattrocelliElizabeth M McNally
Mar 6, 2021·Orphanet Journal of Rare Diseases·Stephanie KourakisEmma Rybalka
Apr 8, 2021·Cellular and Molecular Life Sciences : CMLS·Alicja Starosta, Patryk Konieczny
Oct 29, 2021·Biochemical Society Transactions·Filipp FrankXu Liu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.